Obesity Management: Lifestyle Modification/Bariatric Surgery.

Slides:



Advertisements
Similar presentations
Oral Hypoglycemic Drugs And Classifications
Advertisements

Syndrom of Insulinoresistance. = group of risk factors leading to early progressive (accelerated) atherosclerosis Atherosclerosis could lead to the ischaemic.
A CASE from Weight Loss Clinic
Clinical Presentation of Type 2 Diabetes 1. Risk Factors for Prediabetes and Type 2 Diabetes Family history of diabetes mellitus Cardiovascular disease.
Sex Differences in Overweight & Obesity.
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.
Regulation of food intake. Food intake Regulation –Endocrine Adipose tissue Pancreas Liver Muscle –CNS.
Monash University Student Information Session Professor Bronwyn Kingwell.
The endocrinological: insulin resistance-deficit secretion, incretins, intestinal hormones and microbiota Dr Alexander Miras NIHR Clinical Lecturer Diabetes.
Severance Institute for Vascular & Metabolic Research Serum Osteocalcin is Involved in the Pathogenesis of Exercise-Induced Improvements in Adiposity and.
Diabetes Mellitus.
Adiposity in CVD. Role of adipose tissue in atherogenesis Adapted from de Luca C, Olefsky JM. Nat Med. 2006;12:41-2. Lau DCW et al. Am J Physiol Heart.
Diabetes and Aging MCB 135K Laura Epstein 4/14/06.
Molecular Mechanism of Metabolic disorders Shinichi Oka, PhD Department of Cell Biology and Molecular Medicine Rutgers New Jersey Medical School MSB-I543.
Source: International Chair on Cardiometabolic Risk Fatty Acid Metabolism in Humans Michael Jensen, MD Division of Endocrinology.
February 16, Gainesville, Florida
LONG TERM BENEFITS OF ORAL AGENTS
Goals: 1) Understand the mechanism for ↑LDL in Type II diabetes 2) Having previously established the link between endothelial cell damage (loss of inhibitory.
Diabetes Mellitus (Lecture 2). Type 2 DM 90% of diabetics (in USA) Develops gradually may be without obvious symptoms may be detected by routine screening.
Hyperglycemia at the Vessel Wall. Potential hyperglycemia-induced tissue damage Brownlee M. Diabetes. 2005;54: Repeated acute changes in cellular.
Factors Released from Adipose Tissue and their Physiological Relevance
PANCREATIC HORMONES-II Dr.Mohammed Sharique Ahmed Quadri Assistant professor Almaarefa College 1.
Reem Sallam, MD, MSc. PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
Dr. Amr S. Moustafa, MD, PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
Mechanisms linking obesity with cardiovascular disease
Obesity & Inflammation: Relationships to Type 2 Diabetes and CVD Hannah Coakley January 10 th, 2014.
Diabetes mellitus. Normal endocrine pancreas 1 million microscopic clusters of cells 1 million microscopic clusters of cells Β,α,δ,PP cells Β,α,δ,PP cells.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 2.
STEVIA SYMPOSIUM LEUVEN July 2009 EFFECT OF STEVIOSIDE ON ATHEROSCLEROSIS IN A MOUSE MODEL OF THE METABOLIC SYNDROME Paul Holvoet Atherosclerosis and Metabolism.
Plasminogen-Activating Inhibitor-1 (PAI-1) High PAI-1 associated with: Obesity (especially visceral), possible fatty liver. 2,3,4 Inflammation and oxidative.
Vascular Effects of Insulin: Implications for Hyperglycemia Management.
IR and Hyperinsulinemia Insulin Resistance: A Survival Mechanism, Gone Awry Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
© 2004, Wellsource Inc. Low Carbohydrate Diet and LDL Cholesterol Levels 119 men and women, 24 weeks On the low carb diet, LDL increased slightly On low.
Genetic Predisposition Environmental Factors Obesity TYPE 2 DIABETES
The Obesity/Diabetes Epidemic: Adiposopathy & Obesity- The New Disease! Dx & (Rx) of Insulin Resistance & Early DM Part 5 Stan Schwartz MD, FACP, FACE.
Diabetes Mellitus Type 2
The Obesity/Diabetes Epidemic: Adiposopathy & ‘Obesity’- The New Disease! Weight Management in Obesity and DM: Emphasis on New Medical Therapies Stan Schwartz.
Oral Diabetes Medications Carol Cordy, MD. Goals Understand how type 2 diabetes affects many organs and how this changes over the course of the illness.
Insulin Resistance Progression to Diabetes Part 3.
METABOLISM of ADIPOSE TISSUE 2. LF UK Prof. Rudolf Poledne, PhD.
Metabolic Syndrome Endocrine Block 1 Lecture Dr. Usman Ghani.
In the name of God.
Chapter 5 Type 2 diabetes.
What is Microvascular Disease?
Endocrine Block 1 Lecture Dr. Usman Ghani
Endocrine Block Dr. Usman Ghani
بسم الله الرحمن الرحيم.
Metabolic Changes in Diabetes Mellitus
Metabolic Changes in Diabetes Mellitus
Insulin action is reduced in obesity
Endocrine Block 1 Lecture Dr. Usman Ghani
Type 1 Diabetes Mellitus
Vascular biology of metabolic syndrome
Fat Chance: Not Much against NKT Cells
Advanced Nutrition Diet and Cardiovascular Disease 1
White adipose tissue (HFD)
Adipose tissue and reproduction in women
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
DIABETES MELLITUS. DIABETES MELLITUS It is a syndrome of impaired carbohydrate, protein and fat metabolism caused by either lack of insulin secretion.
Volume 116, Issue 2, Pages (January 2004)
IKKɛ: A Bridge between Obesity and Inflammation
High Glycemic Index Metabolic Damage – a Pivotal Role of GIP and GLP-1
Adipose Tissue as an Endocrine Organ
A whole body model for both glucose and fatty acid metabolism
Figure 2 Mechanisms of crosstalk between adipocytes and the kidney
Effect of metformin on glycemic control, insulin secretion, and insulin sensitivity in T2D. Effect of metformin on glycemic control, insulin secretion,
Glucagon – A hormone from pancreas Lecture NO: 2nd MBBS
Adipose tissue, adipokines, and inflammation
Adipose Tissue as an Endocrine Organ
Presentation transcript:

Obesity Management: Lifestyle Modification/Bariatric Surgery

Comparison of Diets: 12-Month Weight Loss a Atkins n=77 Weight Loss (kg) Zone n=79 b LEARN n=79 b Ornish n=76 b

Stephen N. Jones, MD, FRCP Chief, Division of Diabetes, Endocrinology and Metabolism Mark Collie Professor of Medicine and Molecular Physiology and Biophysics

Identifying the Glycemic Burden Fasting Preprandial Postprandial Hepatic glucose output Hepatic glucose output Glucose disposal Bolus insulin secretion Bolus insulin secretion 24-Hour Glucose

Why Care about Postprandial Hyperglycemia (PPHG)? Coagulation Oxidative Stress Oxidative Stress Increased Inflammatory Markers Increased Inflammatory Markers Oxidized LDL Oxidized LDL Microvascular disease Microvascular disease Hyper TG Hyper TG CVD PPHG

Maintaining Balance: Postprandial Physiology and the Pathogenesis of Disease John Davis, MD, FRCP Chief, Diabetes, Endocrinology and Metabolism Jack Collie Professor of Medicine, Molecular Physiology and Biophysics

Current View of the Action of Insulin Anti-inflammatory  NF-KB,  IkB,  MCP-1,  ICAM-1,  CRP Anti-inflammatory Antithrombotic  TF,  PAI-1 Antithrombotic Vasodilation and platelet inhibition  NO release,  cAMP,  eNOS Vasodilation and platelet inhibition  NO release,  cAMP,  eNOS Antioxidant  ROS Antioxidant Mechanism of the benefit of insulin in acute illness

Abdominal Adiposity There is No Time to Weight Michael Black, M.D. Mayo College of Medicine

FFA and Obesity  molkg LBM -1 min -1 * *  mol/L

Visfatin Leptin Adipsin (ASP) Resistin Angiotensinogen RBP- 4 IL-6 Adipocyte Adipose Tissue as Endocrine Cells AdiponectinAdiponectin Insulin sensitivity Improved metabolism